Stroke is the third leading cause of death and long-term disability world wide 1 . The burden of stroke is high and growing in economically developing countries, including China 2 . Stroke accounted for 21.6% of total mortality in men and 20.8 % of total mortality in women in China 3 . In addition, it was estimated that seven million Chinese people had prevalent stroke in 2004 4 . The incidence and prevalence of stroke and proportion of ischemic stroke is gradually increasing in the Chinese population 5, 6 . Prospective cohort studies and clinical trials have documented that high blood pressure (BP) is the most important modifiable risk factor for the incidence of stroke [7] [8] [9] . However, the relationship between acute phase BP and clinical outcome among acute ischemic stroke patients is much less certain 10, 11 .
Several studies did not show that elevated BP related to poor outcome 20, 21 .
There are currently few data on the relationship between acute phase BP and short-term clinical outcome among acute ischemic stroke patients in Chinese populations. We investigated the association between systolic and diastolic BP levels in the first 72 hours following admission and death in-hospital and neurologic deficiency among acute ischemic stroke patients.
METHODS

Study participants
Acute ischemic stroke patients were recruited from four hospitals in Shandong province, China. All patients with a clinical diagnosis of acute ischemic stroke admitted to the four hospitals from 1 January 2006 to 31 December 2008 were potentially eligible for the study. However, only those cases confirmed by a computed tomography (CT) scan or magnetic resonance imaging (MRI) were included in the study. A team of investigators including neurologists reviewed the eligibility of study participants. Among 2868 acute ischemic stroke patients admitted to the four hospitals during the study period, 2675 had a CT scan or MRI confirmed ischemic stroke and were included in this analysis. A total of 193 patients were excluded from our analysis because of lack of a CT scan or MRI test. Stroke patients who were not admitted into the four hospitals including those who died outside of hospitals were not included in this analysis. This study was approved by Soochow University School of Radiation Medicine and Public Health Ethics Committee.
Data collection
Baseline data were collected within the first 24 hours of hospital admission by in-person interview with patients or their family members (if patients were not able to communicate). Data on demographic characteristics, life-style risk factors, medical history, clinical laboratory tests, and imaging data (CT and MRI) were obtained using a standard questionnaire administered by trained staff. Cigarette smokers were defined as having smoked at least one cigarette per day for one year or more. The amount and type of alcohol consumed during the past year was collected. Alcohol consumption was defined as consuming one or more alcoholic drinks per day during the last year. Blood pressure measurements were taken in the first 72 hours (one measurement every eight hours) after admission while the study participants were in the supine position, using a standard mercury sphygmomanometer according to a standard protocol 22 . The first and fifth Korotkoff sounds were recorded as systolic and diastolic BP, respectively. Plasma glucose was measured using a modified hexoki-nase enzymatic method. Total cholesterol, high-density lipoprotein (HDL)-cholesterol, and triglycerides were analyzed enzymatically on a Beckman Synchron CX5 Delta Clinical System (Beckman Coulter, Inc., Fullerton, California, USA) using commercial reagents 23 . Low-density lipoprotein (LDL)-cholesterol levels were calculated by the use of the Friede wald equation 24 . If a patient died in the hospital, a study staff member recorded the death on the event form and obtained the death certificate. If a patient survived the acute stroke, the study neurologists conducted a comprehensive clinical evaluation using National Institutes of Health (NIH) stroke scale (NIHSS) at discharge. The study outcomes was defined as death during hospitalization and neurologic deficiency (NIHSS≥10) at discharge.
Statistical analysis
Patients were divided into two groups, with study outcome and without study outcome. The mean and standard deviation of continuous variables and proportion of categorical variables at hospital admission were calculated and compared between patients with study outcome and without study outcome. Patients were also grouped by BP level (systolic BP<140, 140-159, 160-179, 180-219, ≥220 mmHg or diastolic BP<90, 90-99, 100-109, 110-119, ≥120 mmHg). Multiple logistic regression analysis was used to examine the association between BP and study outcome adjusted for age, gender, alcohol consumption, cigarette smoking, dyslipidemia, hyperglycemia and histories of hypertension, diabetes, coronary heart disease, auricular fibrillation and rheumatic heart disease, and family histories of stroke, hypertension and diabetes, and consciousness level and complications including myocardial infarction, heart failure, renal failure and pneumochysis at admission. The presence of a linear association was tested using the median systolic and diastolic BP in each of the categories as a continuous variable in the multiple logistics models. Statistical analyses were conducted using SAS statistical software (version 9.1; SAS Institute Inc, Cary, North Carolina, USA).
Results
A total of 2675 ischemic stroke patients were included in our analysis, there were 2470 patients without study outcome and 205 patients with study outcome (19 deaths and 186 patients with NIHSS≥10). Table 1 presents the demographic and clinical characteristics at admission by study outcome. Those with study outcome were more likely to have high LDL-C, hyperglycemia, histories of auricular fibrillation and rheumatic heart disease. There was no significant difference in age, gender, smoking, alcohol consumption, high TC, high TG, low HDL-C, family history of stroke, family history of hypertension, family history of diabetes between patients with study outcome and without study outcome.
Participants with study outcome had higher average systolic and diastolic BP levels in the first 72 hours after admission compared with those without study outcome, but the difference did not reach statistical significance ( Table 2 ). The median duration of hospitalization was 13 days for patients with study outcome and 15 days for patients without study outcome, respectively. The median time from onset to admission was 19 hours for patients with study outcome and 48 hours for patients without study outcome, respectively.
There were positive and significant associations between high systolic and extreme high diastolic BP levels in the first 72 hours of admission and study outcome among patients with acute ischemic stroke ( Table 3 ). Systolic BP of 180-219 mmHg or more was associated with 3.29-fold higher odds of study outcome compared to normal systolic BP after adjustment for important covariates (there was one death among only two patients with systolic BP≥220 mmHg in total paricipants). There was a trend that the risk was increased with elevated systolic BP (P <0.05). Similarly, the patients with diastolic BP ≥120 mmHg had more risk of study outcome compared to those with normal diastolic BP (P <0.05). However, a significant association between mild high diastolic BP and risk of study outcome was not found in the analysis.
DISCUSSION
Our study found a statistically significant association between elevated systolic (≥180 mmHg) and diastolic (≥120 mmHg) BP in the first 72 hours of admission and early death or neurologic deficiency (NIHSS≥10) among acute ischemic stroke patients. In multivariate logistic analysis, we also adjusted for consciousness level and complications including myocardial infarction, heart failure, renal failure and pneumochysis at admission, which could reflect the stroke severity. These findings appear to imply that high systolic BP and extreme high diastolic BP after onset of ischemic stroke could predict a poor 14 showed that systolic BP≥160 mmHg within 24 hours of acute stroke (219 patients) was associated with an increased hazards ratio of 2.41 (95% CI: 1.24-4.67) for long-term mortality after adjustment for multiple variables, compared to the reference group (140-159 mmHg). Ahmed's study 15 showed that the odds ratio for combined death or dependency at Day 21 of stroke onset was significantly higher in patients with high initial BP than that in those with normal initial BP in multiple logistic regression analyses. Some observational studies in western populations found a U-shaped association 16, 17 , such that extreme low and high BP values were associated with poor outcome after stroke onset. Others did not find a significant association between admission BP and poor outcome among acute ischemic stroke patients 20,21,25 . Aslanyan's study 20 showed that baseline MAP was not associated with poor ischemic stroke outcome. However, variables describing the course of BP over the first 2.5 days had a marked and independent relationship with one and three month outcome. The effect of BP reduction among acute stroke patients is much less certain 11, 26 . For many years there has been argument regarding whether to lower or to raise BP and whether to continue or to stop antihypertensive treatment among acute stroke patients 11 . The best way to answer this question is to carry out randomized clinical trials. Eveson et al 27 conducted a pilot study about effects of lowering BP among acute ischemic stroke patients. In their pilot study, a total of 40 hypertensive acute ischemic stroke patients were randomized to a lowered BP group (n = 18) who received treatment of lowered BP for 14 days and control group (n = 22), and stroke outcome measures were assessed at Day 14. Their findings showed that neurologic and functional measures were similar between groups. Recently, Potter and colleagues 28 published the findings of their pilot trial on controlling hypertension and hypotension immediately post-stroke (CHHIPS), among 179 patients with cerebral infarction or cerebral haemorrhage and hypertension. Their findings showed that there was no evidence of early neurological deterioration with active lowering BP treatment despite the significantly greater fall in systolic BP within the first 24 hours in lowering BP group compared with placebo. However, three month mortality was much lower in lowering BP group compared with control group. It must be stressed that the two pilot studies are of small sample, a large randomized clinical trial still needs to be conducted to determine the effects of lowering BP on clinical outcome for acute ischemic stroke.
LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES
There is evidence that cerebral blood flow becomes dependent on systemic BP after a loss of cerebrovascular autoregulation and that insufficient cerebral perfusion pressure through the ischemic penumbra may increase the risk of neurological damage 29, 30 . However, in a meta-analysis 31 which assessed the effect of antihypertensive agents on cerebral blood flow and flow velocity, the authors believed that there was little existing evidence that antihypertensive agents reduce cerebral blood flow in spite of their effects of lowering BP.
Acute phase BP recorded in our study, and in other observational studies, might reflect the pathophysiological responses to acute ischemic stroke and the severity of disease. Our study was limited in that it was an observational study. Only a randomized control clinical trial on BP treatment can determine the causal effect of lowering BP on mortality and neurologic deficiency among acute ischemic stroke patients 11 .
CONCLUSION
In summary, our study found that systolic BP≥180 mmHg and diastolic BP≥120 mmHg were significantly and positively associated with death in-hospital or NIHSS≥10 at discharge among patients with acute ischemic stroke. This study suggests that a large randomized controlled clinical trial is needed to test the potential beneficial effect of lowering BP in acute ischemic stroke patients.
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# adjusted for age, gender, alcohol consumption, cigarette smoking, dyslipidemia, hyperglycemia and histories of hypertension, diabetes, coronary heart disease, auricular fibrillation and rheumatic heart disease, family histories of stroke, hypertension and diabetes, consciousness state and complications at admission. SBP=systolic blood pressure; DBP=diastolic blood pressure. 
